SERNOVA CORP.

Profile

Company Names

SERNOVA CORP.

Addresses

700 COLLIP CIRCLE, SUITE 114, LONDON, A6 N6G 4X8

120-700 COLLIP CIRCLE, LONDON, A6 N6G 4X8

Phone Numbers

519-858-5126

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CANADA (FEDERAL LEVEL)

Total Amount Raised:

$737,467.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2024-09-03 
$473,128.00 
$1,040,881.00 
$567,753.00 
Equity 
6
2020-09-22 
$19,158.00 
$41,509.00 
$22,351.00 
Equity 
5
2019-08-30 
$100,343.00 
$250,858.00 
$150,515.00 
Equity 
4
2016-06-30 
$10,570.00 
$25,367.00 
$14,797.00 
Equity 
3
2012-03-30 
$85,077.00 
$250,502.00 
$165,425.00 
Equity 
2
2010-06-04 
$19,570.00 
$39,140.00 
$19,570.00 
Equity 
1
2010-04-28 
$29,621.00 
$49,638.00 
$20,017.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
BACHA 
DIRECTOR
JEFFREY A. 
 
BACHA 
DIRECTOR
DEBORAH M. 
 
BROWN 
DIRECTOR
RALPH 
 
DEITERDING 
EXECUTIVE OFFICER
SEAN 
 
HODGINS 
EXECUTIVE OFFICER
FRANK A. 
 
HOLLER 
DIRECTOR
HANS 
 
MADER 
DIRECTOR
ANNEMARIE 
 
MOSELEY 
DIRECTOR
BERND 
 
MUEHLENWEG 
DIRECTOR
MODESTUS 
 
OBOCHI 
EXECUTIVE OFFICER
JAMES 
T. 
PARSONS 
DIRECTOR
JONATHAN 
 
RIGBY 
EXECUTIVE OFFICER, DIRECTOR
NICHOLAS 
 
ROSSETTOS 
EXECUTIVE OFFICER
STEVEN 
 
SANGHA 
DIRECTOR
G. WILLIAM 
 
SMETHURST 
EXECUTIVE OFFICER
DAVID 
 
SWETLOW 
EXECUTIVE OFFICER
PHILIP 
 
TOLEIKIS 
EXECUTIVE OFFICER, DIRECTOR
PHILIP 
TOLEIKIS 
EXECUTIVE OFFICER, DIRECTOR
BRUCE 
 
WEBER 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-09-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-04 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#